Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert M Sabbas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Technology in Cancer Research & Treatment|May 27, 2004
HDR brachytherapy with surface applicators: technical considerations and dosimetryAlbert M Sabbas, Fridon G Kulidzhanov, Joseph Presser, et al.
Neuroscience Letters|April 18, 2012
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cellsAlexander M Stessin, Demirkan B Gursel, Allie Schwartz, et al.
Urology|May 2, 2012
Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapyA Gabriella Wernicke, Michael Shamis, Weisi Yan, et al.
Brachytherapy|October 24, 2009
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective studyA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Journal of Cancer Research and Therapeutics|May 19, 2010
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resectionA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Technology in Cancer Research & Treatment|May 27, 2004
HDR brachytherapy with surface applicators: technical considerations and dosimetryAlbert M Sabbas, Fridon G Kulidzhanov, Joseph Presser, et al.
Neuroscience Letters|April 18, 2012
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cellsAlexander M Stessin, Demirkan B Gursel, Allie Schwartz, et al.
Urology|May 2, 2012
Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapyA Gabriella Wernicke, Michael Shamis, Weisi Yan, et al.
Brachytherapy|October 24, 2009
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective studyA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Journal of Cancer Research and Therapeutics|May 19, 2010
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resectionA Gabriella Wernicke, David L Sherr, Theodore H Schwartz, et al.
Pageof 1